Format of Forwarding Letter

GOVERNMENT OF INDIAOFFICE OF THE ADDL. D.G. & MEDICAL SUPERINTENDENTV.M.M.C. & SAFDARJANG HOSPITALNEW DELHI-110029No. : Q-1-MS(1to 10)/2012-TENDER NOTICEAddl. D.G. & M.S. Safdarjang Hospital, New Delhi invites tenders in sealed envelopefor the procurement of drugs/Medicines of the following groups for S.J. Hospital & Dr.R.M.L. Hospital, New Delhi from the eligible firms, preferably manufacturers.Sn. Q-1-MS(no)Group Medicines / drugs Date of TenderopeningTime ofopening1. Q-1-MS(9) H Contrast Media 29/05/2012 10.30 amELIGIBILITY CRITERIA1. EMD: a) Earnest money deposit of `1,00,000.00 (Rupees One lakh only) for each groupexcept of group I, and `25,000.00 (Rupees Twenty Five Thousand only) for group I, inthe shape of Demand Draft only, drawn in favour of the Medical Superintendent,Safdarjang Hospital, New Delhi should be attached with the tender form, failing whichthe tender will be rejected. b) The Tender Number, due date and complete address of thefirm should also be written on the back of the demand draft.2. DRUG LICENSE: A valid drug license / import License from the drug controller forthe manufacture /Import of the medicine/drug quoted. If revalidation of drug license hasbeen applied for the copy of application to State Drug / Licensing authority may beattached with a certificate that application for renewal was made within time frame asper Drug and Cosmetic Act as amended up to date and that has not been deleted bylicensing authority3. QUALITY: a) Manufacturing firms should be registered with the Directorate General ofQuality Assurance (D.G.Q.A.), or should have Good Manufacturing Practice (G.M.P.)certificate as per Revised Schedule ‘M’ of Drugs & Cosmetic Act for indigenous drugs.b) For imported drugs, good manufacturing practice (G.M.P) certificate verified by theState Drug Controller / Drug Controller of India. In accordance with the W.H.O.recommendations (in short called WHO – GMP Certificate) should be furnished for thedrug/medicine quoted.4. EXPERIENCE: The bidder should have not less than 2 years of manufacturing andmarketing experience for the specified product duly supported by documentary evidenceexcept in case of new drugs5. ANNUAL TURNOVER: The Manufacturing firms should have minimum annualturnover of :a. `50 crores (Fifty crore) for GROUP A -1( higher antibiotics)b. `12 crore (Twelve crores) for GROUP A-2, B, C, D, E, F, G and H (bloodproducts and other items except Misc. Drugs),c. `5 crores (Five crores) for Group-IA complete set of Tender documents including terms and conditions along with list of

drugs/medicines for each group can be obtained from the Medical store Deptt. SafdarjangHospital, New Delhi on written request and on cash payment of `500/- (Five HundredRupees only) in Accounts Department for each group/tender (Non-refundable), on anyworking day between 10.00 AM and 1.00 PM and on Saturdays up to 12.00 Noon. TheTender can also be downloaded from hospital website www.vmmc-sjh.nic.in and in such casetenderer has to enclose along with tender DD/Pay Order a sum of `500/- (Five hundred only)drawn in favour of Addl. DG & MS, Safdarjang Hospital, New Delhi payable at New Delhi.The tender documents are non - transferrableManufacturing firms or authorized distributors should submit their bids in TWOPARTS i.e. Techno-commercial bid and Price Bid as detailed in the terms and conditions,in separate sealed envelope. Tenders under sealed Cover should be dropped into the Tenderbox kept in Addl. DG & MS Office block, Safdarjang hospital, ND. Our reference number ofeach tender and date of opening should be mentioned on the top of Sealed Envelope. Tenderswill be opened on scheduled date and time in the presence of participating tenderers. If incase, the date of opening falls on a public holiday, the same will be opened on the nextworking day at 10.00 a.m.Bidders are requested to watch for any modifications / corrigendum in thewebsite.Please read the terms and conditions carefully before filling the tender forms.Addl. DG & MS, Safdarjang Hospital, New Delhi reserves the right at his discretionto accept or reject any tender at any stage in part or the full, without assigning any reasonwhatsoever.Sd/-S. A. G. Officer / C.M.O. (Stores)For Addl. D.G. & M.S. Medical Store

Format of Forwarding LetterFORWARDING LETTER(To be filled in by the tendering party in official letter head)The Medical Superintendent,Safdarjang Hospital,New Delhi-110029Tender Enquiry No. & date: Q-1-MS(9) 29/05/2012Date & Time of opening of tender: 29/05/2012 … 10.30 amGroup of Medicine for Which Quoted : H (Contrast Media )Sir,With reference to the above Tender Enquiry I/We are submitting herewith our tender documents……….The tender document is duly paginated and contains from page No 1 to… … … …A checklist chronologically indicating documents attached in original/copies duly attested by Gazetted Officeras per Clause 22 of tender document is also enclosed.CHECKLISTS.No. DOCUMENTS ENCLOSED YES/NO PAGENO.1 EMD for Rs.1,00,000/-2 Valid Drug License/Import license for quoted medicine/drug3 Valid DGQA/Revised Schedule ‘M’/WHO GMP certificates4 The bidder should have not less than 2 years of manufacturing andmarketing experience for the specified product duly supported bydocumentary evidence except in case of new drugs5 Copy of up to date returns/acknowledgement from the department of trade& taxes with TIN No.6 Certificate to the effect that all the terms & conditions mentioned in thetender document are acceptable as per Clause 2 (ii) of tender document7 Latest Audited Balance Sheet of Manufacturing Firm (Annual Turn overfor the last year)8 Latest certificate of authorization from the manufacturer for the quoteddrugs/medicines valid at least for one year9 Latest certificate regarding the blood products being free from HIV, HBV& HCV viruses10 Undertaking from the firm to supply the quoted drugs/medicines withinthe stipulated time period11 Affidavit regarding the non blacklisting of the firm or any of its productsby any Central / State Govt organisation.12 Certificate issued by Central/State Drug Controller/Licensing Authority incase newly introduced medicines/drugs13 Soft copy of the documents in the form of CD14 Undertaking to replace the defective items if any at the cost of supplier15 Receipt of purchase of tender document (for Rs.500=00)16 Alphabetical Index of drugs quoted in the present tender together withpage no.(s) of Drug Licence, Schedule M or WHO GMP Certificate andmarketing & manufacturing certificates.Name (s) and Signature (s) of the tenderer with stamp of the firm

GOVERNMENT OF INDIAOFFICE OF THE MEDICAL SUPERINTENDENTSAFDARJANG HOSPITAL, NEW DELHI-110029Rate enquiry for Safdarjang Hospital, New Delhi / Dr. R.M.L. Hospital, New DelhiPrice of Form Rs.500/- (Per Group)ADVERTISED TENDER ENQUIRYTENDER NO & DATE : Q-1-MS( 9 ) dt. 29/05/2012BRIEF DESCRIPTION OF ITEMS (Group) : H (Contrast Media )TIME & DATE OF OPENING OF TENDER : 29/05/2012 … 10.30 amAMOUNT OF BID SECURITY : Rs. 1,00,000.00 (Rupees One lakh only)T E R M S A N D C O N D I T I O N SOnly those firms will qualify to compete, who meet the following eligibility criteria1. ELIGIBILITY CRITERIAi. EMD: Earnest money deposit of Rs. 1,00,000.00 (Rupees One lakh only) for each group exceptGroup I, and Rs. 25,00.00 for group I, in the shape of Demand Draft only, drawn in favour of theMedical Superintendent, Safdarjang Hospital, New Delhi should be attached with the tender form,failing which the tender will be rejected. The Tender Number, due date and complete address ofthe firm should also be written on the back of the demand draft.ii. DRUG LICENSE: A valid drug license / import License from the drug controller for themanufacture /Import of the medicine/drug quoted. A valid drug license / import License from thedrug controller for the manufacture /Import of the medicine/drug quoted. If revalidation of druglicense has been applied for the copy of application to State Drug / Licensing authority may beattached with a certificate that application for renewal was made within time frame as per Drugand Cosmetic Act as amended up to date and that has not been deleted by licensing authorityiii. QUALITY: Manufacturing firms should be registered with the Directorate General of QualityAssurance (D.G.Q.A.), or should have Good Manufacturing Practice (G.M.P.) certificate as perRevised Schedule ‘M’ of Drugs & Cosmetic Act for indigenous drugs. For imported drugs, goodmanufacturing practice (G.M.P) certificate verified by the State Drug Controller / Drug Controllerof India. In accordance with the W.H.O. recommendations (in short called WHO – GMPCertificate) should be furnished for the drug/medicine quoted.The firm should clearly highlight the quoted item(s) in the list of DGQA / WHO-GMP certificates& Drug license.iv. EXPERIENCE: The bidder should have not less than 2 years of manufacturing and marketingexperience for the specified product duly supported by documentary evidence except in case ofnew drugs.v. ANNUAL TURNOVER: The Manufacturing firms should have minimum annual turnover of :a. Rs. 50 crores (Fifty crore) for GROUP A -1( higher antibiotics)b. Rs 12 crore (Twelve crores) for GROUP A-2, B, C, D, E, F, G and H (blood products andother items except Misc. Drugs),c. Rs 5 crores (Five crores) for Group-I(The annual audited Balance Sheet of the manufacturing firm for the last financial year should beenclosed in all cases).2. SUBMISSION OF BIDSi. The bidders shall submit their bids in two parts in separate sealed covers marked as a)“TECHNO-COMMERCIAL BID” b) “PRICE BID” as the case may be. Both the sealedenvelopes should also have the Tender No., Date of Opening, Group of Items, name & addressof the bidder, marked on the sealed envelopes. Both the sealed envelopes should be put in anouter Main Cover which should also be sealed and marked with Tender No., Date of Opening,Group of Items, name & address of the bidder.

ii. TECHNO – COMMERCIAL BID : All the documents as mentioned in the EligibilityCriteria, Clause 22 of the terms & conditions and check list (enclosed), any other documentwhich doesn’t give an indication of the price, List of items quoted with specifications /composition of the item, pack size etc. should be enclosed in the Techno-Commercial Bid.(THE COLUMN FOR PRICE SHOULD BE LEFT BLANK IN TECHNO – COMMERCIALBID). If price is mentioned in the techno-commercial bid, the bid is likely to be rejected. Thebid should be duly type written, free from erasing/over-writing/cuttings along with a soft copyof the same in non convertible PDF format.iii. PRICE BID: List of items quoted with specifications / composition of the item, pack size etcexactly as submitted in the Techno-commercial bid along with the price of the items should beenclosed in the Price Bid (in duplicate). It should be duly type written, free from erasing/overwriting/cuttingsalong with a soft copy of the same in non convertible PDF format. The rateswill be valid for a period of not less than one year or till new tenders are finalized for nextfinancial year which ever is lateriv. It may be noted that when the main cover is opened on the date and time scheduled for bidopening, only the technical bids will be opened and read out in public.v. Bidders whose techno-commercial bids are found substantially responsive will be informed ofthe date and time of opening of their price bids. Price bids of others will be returned to themunopened before, opening the price bids of others. If some of the items of a bidder aretechnically approved, the price of other items which are not approved shall be ignoredvi. The documents should be dropped in the tender box kept at the Ground Floor in Addl D.G.and Medical Superintendents Office, before the date and time of the Tender Opening.vii. All the pages of tender documents should be properly numbered and total number ofpages be indicated on the forwarding letter as per format attached.viii. For newly introduced drugs, the manufacturer will be required to submit a certificate ofmarketing from the Central / State Drug Controller / Licensing Authority3. UNDERTAKINGi. The firms should give an undertaking that they are bound to supply the quotedmedicines/drugs within the stipulated time, failure of which would render the firm liable foraction as mentioned in clause 15 (i) of the tender.ii. The firm is required to submit a certificate in the format as “I / we have read and understoodall the terms and conditions governing the tender. I / we agree to abide by all the terms andconditions of the tender enquiry”4. BID OPENINGi. The Tender Opening Committee (TOC) will open bids in the presence of bidder’srepresentative, who choose to intend, at the time and date specified in the invitation for bidsand in the following location.OFFICE OF THE MEDICAL SUPERINTENDENTSAFDARJANG HOSPITALNEW DELHI-110029ii.iii.The bidders representatives who choose to attend the bid opening, shall bring with them aletter of authority from the bidder on the letter head for having been authorized to be presentat the time of opening of the bid. In the absence of such a a letter of authority, therepresentative will not be allowed to present and/or to attend the bid opening. The bidder’srepresentatives who are present shall sign a register evidencing their attendance. In the eventof the specified date of bid of opening being declared a holiday for the purchaser the bids shallbe opened at the appointed time and location on the next working day.The TOC will examine the bids to determine whether they are complete, whether required bidsecurity has been furnished, whether the documents have been properly signed, and whetherthe bids are generally in order.

5. TECHNO-COMMERCIAL AND PRICE EVALUATIONi. The constituted Joint Purchase Committee (JPC), on behalf of the purchaser shall determinethe substantial responsiveness of each bid in accordance with the terms & conditions of thebidding documents. For purposes of these clauses, a substantially responsive bid is one,which conforms to all the terms and conditions of the bidding documents without materialdeviations.ii. The Committee may waive any minor informality or non-conformity or irregularity in a bid,which does not constitute a material deviation, provided such waiver does not prejudice oraffect the relative ranking of any bidder.iii. The Committee’s determination as to the substantial responsiveness or otherwise on each bidiv.or consideration of a minor informality or non-conformity or regularity is final and conclusive.The Price bid of only techno-commercially responsive bids/items shall be evaluated by theJPC after opening of the price bids.v. Arithmetical errors will be rectified on the following basis. If there is a discrepancy betweenthe unit price and quantity, the unit price shall prevail and the total price shall be corrected. Ifthe supplier does not accept the correction of the errors, its bids will be rejected. If there is adiscrepancy between the words and of figures the amount in words shall prevail.6. The stores offered should comply with the provisions of the Drug Control Act 1940 and the rulesamended from time to time.7. (i) The manufacturer should preferably participate in the tenders directly. If the bids are submitted throughan authorised distributor, a valid certificate of authorisation, valid for at least one year, should beobtained from the manufacturer. In case the authorised distributor is quoting, all the certificates asrequired in the terms and conditions of tender should be from the manufacturer with their responsibilityand liability. In case the name of the authorised distributor is changed by the manufacturer, acceptanceof the new authorised distributor for supply of drugs shall be at sole discretion of the hospital authorityand the onus of the responsibility would lie with the manufacturer.(ii) The authorised distributor, quoting for a specific item / drug, shall quote the rates of only onemanufacturer in one tender.8. (i) It will be a condition on the approval of the offer that the price charged for the stores supplied to thehospital shall in no event exceed the lowest at which the tenderer sells the stores of identicaldescription to any other individual / Govt or private institution. Violation of this clause will entaildebarring the erring firm from participating in the tender for two consecutive years.(ii) If at any stage during the tenure of the tender, the tenderer reduces the sales price lower than the pricecharged under the agreement, the tenderer will forthwith notify such reductions of the sale price to theMedical Superintendents of Safdarjang Hospital and Dr. R. M. L. Hospital, New Delhi.(iii) The quoted prices should not be in excess of Drug Control Order 1970, and the rules made thereafter asamended from time to time.9 (i) The rates should be quoted strictly as per our specification and per unit as mentioned in the list ofdrugs and supplied accordingly, e.g. in strips of 10 etc.(ii) The pack size and pack size rates should be specifically mentioned and adhered to while supplying thematerial.(iii) The rates of Tablets / Capsules should be quoted in strip pack only, mentioning pack size.(iv) Drug inserts/product inserts which are invariably supplied by the manufacturer/distributor with theproduct at the sale counter/or product brochure must be attached as enclosures with this tender.10. The quantity shown in the schedule is an estimated requirement and it cannot be guaranteed that thesame will be ordered.11. Excise duty(ED), Central Tax(CT), Sales Tax(ST) and other taxes, if chargeable extra, where legallylevied and intended to be claimed, should be distinctly shown along with the quoted price and no suchclaim if any, will be admitted at any later stage on any grounds. However, in the event of any revisionin the existing rates of duties or introduction of any statutory duty and taxes imposed by the Govt., thesame will be paid extra on production of satisfactory documentary proof.

12. No facility regarding CDEC/import license etc. can be given.13. In case of controlled goods by the Govt., the quotation must be sent subject to the prevailing conditionsregarding controlled goods. The price will be paid at the controlled rate or the price offered by the firmwhich ever is less. In case of quotations of controlled goods, the controlled rates of the firm must beclearly mentioned in the quotations.14. (i) The tenderer shall supply the items in single batch only. At the time of supply the manufacturer orauthorised distributor will enclose original chemical analysis report on form 39 (which must mentionthe quantity of active ingredient) for each batch irrespective of quantity of drug supplied at each time.The chemical analysis report must be from the laboratory duly approved by the Govt. / State DrugController and the expenditure incurred shall be borne by the manufacturer / authorised distributor.(ii) List of Govt. approved analytical laboratories or the laboratories as approved by the State DrugController/Drug Controller of India, shall be obtained from the respective deptt. and be attached witheach supply as a proof of its approval. If there is no Govt. approved lab, which has the facility to testthe drug, the firm must enclose a letter to the effect from State / Central Drug Controller at the time ofsupply of drug.(iii)(iv)Manufacturer’s own test report will be treated, merely as an additional documentary proof for thequality of material against each supply made by the manufacturer / authorized distributor.In case of supply of medicines/drugs not manufactured in India, the sole distributors/marketing agentsin India are required to submit the Lab. Analytical Test Report of the Country of Origin along with thecertificate duly attested by the Drug Controller of India / State Drug Controller / Licensing Authorityregarding its permissibility and safe uses in India.(v) Guarantee / Warranty Certificate regarding assurance of the quality of material, under signature of themanufacturer / distributor for each batch should be submitted along with the items supplied. No supplywill be received without the Guarantee/Warranty Certificate and all other requisite documents at thetime of supply.(vi) The medicines / drugs supplied are also liable to be tested at random by chemical analysis from Govt.approved lab / Govt. testing lab without any intimation to the supplier. If the new test report iscontradictory with the test report submitted, the cost incurred on the whole process of testing shall bededucted from their previous due bills and this will be intimated to the supplier later on by the hospitaland / or process of recovery shall be started. Also, if at any stage of use the supplies are foundsubstandard, NO PAYMENT will be made for the entire rejected / substandard batch of that particularitem, even if the supplies have been consumed in good faith and the facts will be notified to the DrugController of India / State Drug Controller for taking necessary action.(vii) The Medical Superintendent of this hospital shall have power to relax Test Report in form 39 up to anorder value of Rs.15,000/-, but Tenderer shall have to provide manufacturer Test Report, undertakingand guarantee certificate at the time of supply.15. (i) If the firm fails to supply the items within the time mentioned in the supply order (unless permitted bythe hospital only in case of a request from the firm mentioning reasons acceptable to the hospital), thesupply order will stand cancelled without any notice at the risk and cost to the firm and that item shallbe procured from the next lowest approved firm (in short called L2). The difference in the cost, paid inextra, shall be deducted from the earlier dues, if any, and / or the firm will be asked to deposit thedifference in the amount in the hospital account so as to compensate for the extra cost borne by thehospital. On the second occasion again, if the firm does not supply, the Security Deposit will standforfeited and they shall not be allowed to participate in future open tender for a period of twoconsecutive years in this hospital. Punitive proceedings, as deemed fit, are also liable to be initiatedagainst that firm.(ii) All participating firms must submit an affidavit on non-judicial stamp paper stating that they or any oftheir products have neither been blacklisted nor debarred from participating in future tenders by anyState Government / Central Government organisations. If at any stage their claim turns out to be false

the said firm will render itself liable for punitive action, as deemed fit. The present tender in which theyhave quoted would be summarily rejected besides being debarred from participation in future opentenders for a period of two consecutive years.16.(i) In case of antibiotics, injections, biological preparations containing vitamins, enzymes and hormones,the supplies should not be beyond the expiry of 1/6 th shelf life at the time of receipt of the store.(ii) The stores tendered should strictly conform to the specifications mentioned, i.e. strength, formulae,quality, packing, etc.(iii) Pertaining to Blood Products, a certificate from an accredited laboratory, indicating that theformulation is free from HIV, HBV and HCV viruses must be furnished for each batch of productsupplied.17. Payment will be made only after the full and final supply of the stores, Lab. Analysis Report and theGuarantee/Warrantee Certificate for each batch. No payment on part supply will be made.18. Labels of all containers, cartons, wrappers, vials, strips etc. should invariably be marked in block letters“CENTRAL GOVT. SUPPLY NOT TO BE SOLD” with the indelible ink in RED COLOUR.19. (i) Quotations should be strictly according to the required specifications and in case of formulations,detailed formula along with the concerned literature be furnished with the name of manufacturer andthe brand under which the product is marketed should also be stated.(ii) All containers, i.e. bottles, tins, cartons, tubes etc. are required to be secured with pilfer proof packingso as to ensure genuineness of the product packed and correctness of its contents and shall be neatlylabelled.(iii) Unutilized items will be notified by this hospital three months in advance to its expiry, and the sameshould be replaced free of cost by the tenderer / firm.20. All certificates as specified in the tender document should be in English language. Alternatively, atranslated copy in English (by an authorised translator), along with the original copy will be accepted.The translated copy should be duly certified / attested by the competent authority.21. (i) Canvassing of any sort or influencing the members of any committee involved in the purchase processat any stage shall be considered for disqualification of bid.(ii) All court cases will be settled in Delhi jurisdiction only.22. THE FOLLOWING DOCUMENTS SHOULD BE ATTACHED WITH TENDER DOCUMENT:(i)(ii)(iii)(iv)(v)Earnest Money Deposit for Rs.1,00,000/-A valid drug license / import License from the drug controller for the manufacture /Import of themedicine/drug quoted. If revalidation of drug license has been applied for the copy of application toState Drug / Licensing authority may be attached with a certificate that application for renewal wasmade within time frame as per Drug and Cosmetic Act as amended up to date and that has not beendeleted by licensing authorityValid DGQA certificates/Revised Schedule ‘M’/WHO-GMP certificates (item quoted to be highlightedclearly).Two years of manufacturing and marketing experience certificate for the specified product except incase of new drugsA copy of up-to-date returns/acknowledgement from the Department of Trade and Taxes with TIN NO.(vi) Certificate to the effect that all the terms and conditions mentioned in the tender document areacceptable.(vii) Latest Audited Balance Sheet of manufacturing firm (annual turnover for the last year).(viii) Latest certificate of authorisation from the manufacturer for the quoted drugs/medicines valid at leastfor one year.

(ix)(x)(xi)Latest Certificate regarding the blood products being free from HIV, HBV and HCV viruses from anaccredited laboratoryUndertaking from the firm to supply the quoted medicines/drugs within the stipulated time period.Affidavit on non-judicial stamp paper regarding the non blacklisting of the firm or any of its productsby any Central/State Govt organisation.(xii) Certificate issued by Central/State Drug Controller/Licensing Authority in case of newly introducedmedicines/drugs(xiii) Soft copy of the documents in the form of CD.(xiv)(xv)Undertaking to replace defective item(s) if any at the cost of supplier as per terms and conditionReceipt of purchase of tender document (for Rs.500/-)(xvi) Alphabetical Index of drugs quoted in the present tender together with page no.(s) of Drug Licence,Schedule M or WHO GMP Certificate and marketing & manufacturing certificates.23. The Competent authority reserves the right to reject the tender at any stage if any discrepancy ordeficiency is found in the tender process.24. Each page of the terms and conditions to be signed by the authorised signatory with official seal of thefirm and attached with the bids.************

Group H (Contrast Media)Sn. Name of Medicine SJHrequirementGroup A Non-Ionic Contrast MediaIohexol1 Iohexol 240mg. in 20ml. & 50 ml. Pack 500/5002 Iohexol 300mg. in 50ml. & 100ml Pack 1000/10003 Iohexol 350 mg in 50ml. & 100ml Pack 1000/3000Iopamidal4 Iopamidal 300mg. in 50ml &100ml Pack 1000/10005 Iopamidal 370mg in 50ml &100ml Pack 4500/4500Iopromide6 Iopromide 300mg. in 50ml & 100ml Pack 1000/10007 Iopromide 370 mg in 50ml & 100ml Pack 1000/1000Ioversol8 Ioversol 300 mg. in 50 ml. & 100 ml. Pack 1000/10009 Ioversol 350 mg. in 50 ml. & 100 ml. Pack 1000/1000Iodixanol10 Iodixanol 320 mg. in 50 ml. & 100 ml. pack 1000/1600Iomeprol11 Iomeprol 300 mg. in 50 ml. & 100 ml. pack 2500/100012 Iomeprol 350 mg. in 50 ml. & 100 ml. pack 1000/100013 Iomeprol 400 mg. in 50 ml. & 100 ml. pack 1500/100014 Iobitridol 300 mg. in 50 ml. & 100 ml. pack 1000/100015 Iobitridol 350 mg. in 50 ml. & 100 ml. pack 1000/1000Group B Ionic Contrast Media1 Meglumine and Sodium Salts in range of 66-68% and 8.3-10% 1000respectively in 50 ml. pack2 Meglumine and Sodium Salts in range of 40-60% and 6.7-18.5% 1000respectively in 50 ml. pack3 Meglumine Salts in range of 60-65% in 50 ml. pack 10004 Sodium Salts in range of 66.8%-70% in 50ml. pack 10005 Sodium and Maglumine Ioxaglate 320 mg. in 50 ml. & 100 ml.pack10001.

Group H (Contrast Media)Sn. Name of Medicine SJHrequirementGroup C MRI Contrast Media1 Gadobenate Dimeglumine 334 mg. / ml. 10 ml. & 20 ml. pack 200/1002 Gadodiamide 287 mg. / ml. in 10 ml. & 20 ml. pack 200/1003 Gadopentetate Dimeglumine 469 mg. / ml. in 10 ml. & 20 ml. 200/100pack4 Meglumine Gdoterate 279 mg. / ml. in 10 ml. & 20 ml. pack 200/100Group D Oral Contrast Media1 Oral Iodinated Contrast Media sodium diatrizoate (41.7% 249mg/ml) in 30 ml & 100 ml pack2.1000/500Total Twenty Five Items